Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/397703

Genotyping and epidemiological metadata provides new insights into population structure of Xanthomonas isolated from walnut trees

Fernandes, C.·Albuquerque, P.·Cruz, L.·Tavares, F.
View original source ↗Export metadata ↓

Abstract

Xanthomonas arboricola pv. juglandis (Xaj) is the etiological agent of walnut diseases affecting leaves, fruits, branches and trunks. Although this phytopathogen is widely spread in walnut producing regions and has a considerable genetic diversity, there is still a poor understanding of its epidemic behaviour. To shed some light on the epidemiology of these bacteria, 131 Xanthomonas isolates obtained from 64 walnut trees were included in this study considering epidemiological metadata such as year of isolation, bioclimatic regions, walnut cultivars, production regimes, host walnut specimen and plant organs. Genetic diversity was assessed by multilocus sequence analysis (MLSA) and dot blot hybridization patterns obtained with nine Xaj-specific DNA markers (XAJ1 - XAJ9). The results showed that Xanthomonas isolates grouped in ten distinct MLSA clusters and in 18 hybridization patterns (HP). The majority of isolates (112 out of 131) were closely related with X. arboricola strains of pathovar juglandis as revealed by MLSA (clusters I to VI) and hybridize with more than five Xaj-specific markers. Nineteen isolates clustered in four MLSA groups (clusters VII to X) which do not include Xaj strains, and hybridize to less than five markers. Taking this data together, was possible to distinguish 17 lineages of Xaj, three lineages of X. arboricola and 11 lineages of Xanthomonas sp. Some Xaj lineages appeared to be widely distributed and prevalent across the different bioclimatic regions and apparently not constrained by the other features considered. Assessment of type III effector genes and pathogenicity tests revealed that representative lineages of MLSA clusters VII to X were nonpathogenic on walnut, with exception for strain CPBF 424, making this bacterium particularly appealing to address Xanthomonas pathoadaptations to walnut.\n\nIMPORTANCEXanthomonas arboricola pv. juglandis is one of the most serious threats of walnut trees. New disease epidemics caused by this phytopathogen has been a big concern causing high economic losses on walnut production worldwide. Using a comprehensive sampling methodology to disclose the diversity of walnut infective Xanthomonas, we were able to identify a genetic diversity higher than previously reported and generally independent of bioclimatic regions and the other epidemiological features studied. Furthermore, co-colonization of the same plant sample by distinct Xanthomonas strains were frequent and suggested a sympatric lifestyle. The extensive sampling carried out resulted in a set of non-arboricola Xanthomonas sp. strains, including a pathogenic strain, therefore diverging from the nonpathogenic phenotype that have been associated to these atypical strains, generally considered to be commensal. This new strain might be particularly informative to elucidate novel pathogenicity traits and unveil pathogenesis evolution within walnut infective xanthomonads. Beyond extending the present knowledge about walnut infective xanthomonads, this study might contribute to provide a methodological framework for phytopathogen epidemiological studies, still largely disregarded.

Explore related subjects

microbiologyPreprint

Keep this discovery

BibTeXRIS

Fernandes, C., Albuquerque, P., Cruz, L., Tavares, F.. 2018-08-22. Genotyping and epidemiological metadata provides new insights into population structure of Xanthomonas isolated from walnut trees. https://doi.org/10.1101/397703

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗
bioRxiv2026

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗
bioRxiv2026

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗